Skip to main content
OpenTrials
Completed

NCT Number: NCT06073054

A Pharmacist Intervention to Improve Mother and Child Health

The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are:

* Will postpartum women who had elevated blood pressure during pregnancy be willing to participate in the study, talk to a pharmacist about their health and the health of their child, and text us their blood pressure measurements? * Will contact with the pharmacist improve the health of the mother and/or the child?

Participants will:

* complete a baseline demographic survey, * be given a blood pressure cuff and taught how to use it, * be asked to text us their blood pressure values 2 times per day for 7 days after enrollment, * complete a phone call with a pharmacist discussing their health and the health of their baby, * text us their blood pressure 1 time per day for 3 days 1 month after enrollment, * have a 1 month follow-up phone call with the research pharmacist, and * complete an exit survey to provide feedback about the study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Iowa Hospitals and Clinics

Iowa City, Iowa, 52242, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • biological mother of a baby attending a 1-week to 6-month well-child visit,
  • received prenatal care at University of Iowa Hospitals and Clinics,
  • had at least 2 elevated blood pressures (>= 130 mmHg systolic or >= 80 mmHg diastolic) during pregnancy,
  • owns a smartphone

Exclusion criteria

  • arm circumference > 17 inches,
  • prisoner status
  • unable to provide own written informed consent

Treatment and study plan

Research Pharmacist

Behavioral

The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.

Primary outcomes

  1. Number of Participants Who Talk to Research Pharmacist

    Time frame: Through study completion, an average of 30 days

    We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.

  2. Number of Participants Who Return BP Measurements

    Time frame: Through study completion, an average of 30 days

    We will calculate the number of participants who return at least one blood pressure measurement via text message.

  3. Percentage of Well-Child Visits Attended

    Time frame: Through study completion, an average of 30 days

    We will calculate the percentage of well-child visits that are attended by each family.

  4. Percentage of Vaccinations Received

    Time frame: Through study completion, an average of 30 days

    We will calculate the percentage of vaccinations received by each child.

Secondary outcomes

  1. Number of BP Measurements Submitted

    Time frame: Through study completion, an average of 30 days

    We will calculate the number of blood pressure values that are submitted by each participant.

  2. Blood Pressure Control

    Time frame: Through study completion, an average of 30 days

    We will determine how many participants' blood pressure is controlled after the intervention.

  3. Number of Participants Satisfied With the Study

    Time frame: Through study completion, an average of 30 days

    We will measure participant satisfaction with the study using an exit survey. Satisfaction will be measured by a response of Extremely Helpful or Helpful on the question- My contact(s) with the pharmacist about my health were....

Sponsors and collaborators

Lead sponsor

University of Iowa

Other

Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 10, 2023
Registry last updated
Aug 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.